O. Watanabe et al., OVERPRODUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR - VASCULAR-PERMEABILITY FACTOR IS CAUSATIVE IN CROW-FUKASE-(POEMS)-SYNDROME, Muscle & nerve, 21(11), 1998, pp. 1390-1397
Crow-Fukase or POEMS syndrome of polyneuropathy, organomegaly, endocri
nopathy, M-protein, and skin changes is a rare multisystem disorder of
obscure pathogenesis that is associated with microangiopathy, neovasc
ularization, and accelerated vasopermeability. We examined the levels
of the vascular endothelial growth factor/vascular permeability factor
(VEGF) in the serum and cerebrospinal fluid (CSF) from 10 patients wi
th this syndrome. Serum VEGF levels were about 15-30 times those in co
ntrol subjects or patients with Guillain-Barre syndrome (GBS), chronic
inflammatory demyelinating polyneuropathy (CIDP), and other neurologi
cal disorders. The CSF VEGF levels, however, were similar to those fou
nd in GBS and CIDP, Elevated VEGF levels in the serum decreased in 7 p
atients with Crow-Fukase syndrome after conventional therapy. The prin
cipal isoform of VEGF in Crow-Fukase syndrome was VEGF165, Elevated VE
GF was independent of M-protein, Our results suggest that the overprod
uction of VEGF is important in the pathogenesis of this disorder. (C)
1998 John Wiley & Sons, Inc. Muscle Nerve 21: 1390-1397, 1998.